Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Genotype (GT)1 and GT2 Infection (MK-3682-011)

NCT02332707 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

443

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Grazoprevir
DRUG: Uprifosbuvir
DRUG: Elbasvir
DRUG: Ruzasvir
DRUG: Uprifosbuvir (+) Grazoprevir (+) Ruzasvir
DRUG: Ribavirin

Sponsor

Merck Sharp & Dohme LLC